Skip to main content
52°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Stoke Therapeutics Inc
(NQ:
STOK
)
11.77
-0.18 (-1.51%)
Streaming Delayed Price
Updated: 10:55 AM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Stoke Therapeutics Inc
< Previous
1
2
3
4
Next >
A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics
June 28, 2024
Via
Benzinga
Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
June 24, 2024
Via
Benzinga
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Analyst Expectations For Stoke Therapeutics's Future
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 04, 2024
Via
Benzinga
Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
April 04, 2024
Via
Benzinga
The Latest Analyst Ratings for Stoke Therapeutics
July 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 27, 2024
Via
Benzinga
What's Going On With Stoke Therapeutics Stock Tuesday?
March 26, 2024
After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of its common stock. The company also intends to grant the underwriters a...
Via
Benzinga
Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates
March 26, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23% to 16,421.62. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 26, 2024
Via
Benzinga
Dow Gains 100 Points; McCormick Posts Upbeat Results
March 26, 2024
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday. The Dow traded up 0.25% to 39,413.30 while the NASDAQ rose 0.27% to 16,448.55. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...
Via
Benzinga
Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February
March 26, 2024
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients
March 26, 2024
New data from Stoke Therapeutics' STK-001 studies reveal significant reductions in seizures and cognitive improvements in children with Dravet syndrome. STK-001 demonstrates promise as a well-tolerated...
Via
Benzinga
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
March 26, 2024
NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 26, 2024
Via
Benzinga
Why Is Check-Cap (CHEK) Stock Up 44% Today?
March 26, 2024
Check-Cap stock is up on Tuesday with heavy trading as CHEK investors react to news of a business combination with Nobul AI.
Via
InvestorPlace
Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday
March 26, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
March 26, 2024
Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001
Via
Benzinga
Why Is Stoke Therapeutics (STOK) Stock Up 99% Today?
March 26, 2024
Stoke Therapeutics stock is up on Tuesday as STOK shares see heavy trading alongside recent positive clinical trial data.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 26, 2024
It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!
Via
InvestorPlace
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Misses Revenue for Q4 2023
March 25, 2024
STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
March 25, 2024
Via
Benzinga
Stoke Therapeutics Stock Rockets On Phase 1/2a Data: Here's Why
March 25, 2024
Stoke Therapeutics reported its fourth-quarter financial results and announced Phase 1/2a end of study data after the bell Monday. The company reported quarterly losses of 60 cents per share which beat...
Via
Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
August 16, 2023
This small-cap biotech might be a hidden gem.
Via
The Motley Fool
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.